Intra-patient controlled trial of Mepilex Lite dressings

Par : Mölnlycke Health Care, avril 28 2014Publié dans :: Radiothérapie

Details of the Patersen Mepilex Lite trial


This article reports on the results of a randomised controlled trial that was undertaken to assess the effect of Mepilex Lite dressings on the full range of radiotherapy-induced skin reactions of breast cancer patients post-mastectomy.


A total of 80 women were recruited from four hospitals in New Zealand with 74 women contributing a full data set for analysis. The first skin area on the chest wall to develop erythema was randomly divided into two similar halves; one was treated with Mepilex Lite dressings, the other half with aqueous cream. Skin reactions were assessed using the Radiation-Induced Skin Reaction Assessment Scale.


Compared with aqueous cream, Mepilex Lite dressings did not significantly reduce the incidence of moist desquamation, however they did reduce the overall severity of skin reactions by 41% (p<0.001), the average moist desquamation score by 49% (p=0.043) and the sum of the moist desquamation time for all patches by 28% from 25 to 18 weeks. Most patients preferred the dressings, found them easy to use and very comfortable to wear.


Mepilex e.m dressings reduce all aspects of radiation-induced skin reactions.

For more information:

Mepilex e.m - Une efficacité prouvée...
Mepilex e.m - Une efficacité prouvée cliniquement

Selon l'OMS, chaque année, environ 900 000 femmes...

Réactions cutanées secondaires à la...
Réactions cutanées secondaires à la radiothérapie

Description des réactions cutanées Les réactions...

Utilisation de Mepilex e.m. en radiothérapie.
Utilisation de Mepilex e.m. en radiothérapie.

Visionner notre vidéo d'accompagnement ici. Nettoyer...

Radiothérapie Webinaires

Facing the challenges of Radiotherapy-Induced Skin ReactionsMay, 2015 (en anglaise seulement)